Literature DB >> 16628679

Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome.

Koichi Tanaka1, Kazue Ozawa, Satoshi Teramukai, Yasutsugu Takada, Hiroto Egawa, Satoshi Kaihara, Yasuhiro Fujimoto, Yasuhiro Ogura, Mureo Kasahara, Masako Ono, Hiroshi Sato, Kenji Takai, Masanori Fukushima, Nagahiro Minato.   

Abstract

The primed status of T cells is markedly different among liver transplant recipients, due to a lifetime of antigen exposure and reduced thymopoiesis by aging, and diseases. This study aims to characterize the preoperative immunological status of CD8+ T cell subpopulations and relate it to the outcome for liver transplant recipients. We classified 112 liver transplant recipients into 5 groups, based on hierarchical clustering of the CD8+CD45 isoform proportion of T cells. In Groups I and II (pediatric), the naive T cell proportion was more than 50%. In adult recipients, Group III was characterized by a naive T cell proportion of 50%, Group IV had the greatest effector/memory T cells (EM), and Group V had the greatest proportion of effector T cells. In Groups IV and V, the effector T cell proportion was considerably higher, and was accompanied by marked downregulation of the CD27+CD28+ subsets and upregulation of interferon gamma (IFN)-gamma, tumor necrosis factor-alpha, and perforin expression. Group V recipients tended to be complicated postoperatively, with a significantly reduced survival rate (1 yr, 66.8%) and markedly reduced Eastern Cooperative Oncology Group performance status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628679     DOI: 10.1002/lt.20705

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

3.  Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients.

Authors:  H Egawa; K Ozawa; Y Takada; S Teramukai; A Mori; K Ogawa; T Kaido; Y Fujimoto; Y Kawaguchi; E Hatano; H Sato; M Ono; K Takai; K Tanaka; S Uemoto
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

4.  Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto; K Ogawa
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

5.  Serial assessment of immune status by circulating CD8 effector T cell frequencies for posttransplant infectious complications.

Authors:  Shinji Uemoto; Kazue Ozawa; Hiroto Egawa; Yasutsugu Takada; Hiroshi Sato; Satoshi Teramukai; Mureo Kasahara; Kohei Ogawa; Masako Ono; Kenji Takai; Masanori Fukushima; Kayo Inaba; Koichi Tanaka
Journal:  Clin Dev Immunol       Date:  2008

6.  Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.

Authors:  Hiroto Egawa; Kazue Ozawa; Yasutsugu Takada; Satoshi Teramukai; Akira Mori; Mureo Kasahara; Kohei Ogawa; Yasuhiro Ogura; Fumitaka Oike; Toshimi Kaido; Masako Ono; Hiroshi Sato; Kenji Takai; Shinji Uemoto
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.